X-Ray Optics for Synchrotron Biomedical Imaging Research

用于同步加速器生物医学成像研究的 X 射线光学器件

• 批准号: 327354-2012
• 负责人: Chapman, LDean
• 金额: $ 3.72万
• 依托单位: University of Saskatchewan
• 依托单位国家: 加拿大
• 项目类别: Discovery Grants Program - Individual
• 财政年份: 2013
• 资助国家: 加拿大
• 起止时间: 2013-01-01 至 2014-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=526932
• 关键词: Ray; Optics; Synchrotron; Biomedical; Imaging

As principal investigator and team leader, Prof. Chapman has led the design, specification, construction, and initial operations of the world-leading BioMedical Imaging and Therapy (BMIT) facility at the Canadian Light Source (CLS). BMIT is now among the global leaders in human and animal health research using synchrotron radiation. In parallel with personally guiding the development of this uniquely Canadian resource, he has developed extensive biomedical and clinical collaborations enabling new research from cancer detection to bone health to gene expression imaging. These collaborations and his continued development and application of advanced imaging technologies provide a rich multidisciplinary environment for training of HQP. He and collaborators have used synchrotron facilities to develop and commercialize imaging technologies for pre-clinical applications, including novel studies of genetics, stroke, and heart attack.

作为首席研究员和团队负责人，Chapman教授领导了加拿大光源（CLS）世界领先的生物医学成像和治疗（BMIT）设施的设计、规范、建设和初始运营。目前，BMIT在利用同步辐射进行人类和动物健康研究方面处于全球领先地位。在亲自指导这一独特的加拿大资源开发的同时，他还开发了广泛的生物医学和临床合作，使从癌症检测到骨骼健康到基因表达成像的新研究成为可能。这些合作以及他对先进成像技术的持续开发和应用，为HQP的培训提供了丰富的多学科环境。他和合作者使用同步加速器设备开发和商业化用于临床前应用的成像技术，包括遗传学、中风和心脏病发作的新研究。